COZAAR Label update October 2022

COZAAR Label update October 2022

3rd Grade

8 Qs

quiz-placeholder

Similar activities

postest

postest

1st - 5th Grade

9 Qs

Colony Stimulating Factors, Erythropoiesis Stimulating Agent

Colony Stimulating Factors, Erythropoiesis Stimulating Agent

KG - University

10 Qs

matières G

matières G

1st - 3rd Grade

10 Qs

bahan tambahan pangan

bahan tambahan pangan

1st - 3rd Grade

10 Qs

FUTBOL

FUTBOL

1st - 5th Grade

10 Qs

LMP - Estándares de Calidad Amb. - Valores Máx. Admisibles

LMP - Estándares de Calidad Amb. - Valores Máx. Admisibles

1st - 3rd Grade

10 Qs

critical care medicine

critical care medicine

KG - Professional Development

10 Qs

Turma 506

Turma 506

1st - 10th Grade

10 Qs

COZAAR Label update October 2022

COZAAR Label update October 2022

Assessment

Quiz

Professional Development

3rd Grade

Medium

Created by

Nthabiseng Mashaphu

Used 2+ times

FREE Resource

8 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

COZAAR is now packed in a pack of 25s, 50s and 100

TRUE

FALSE

2.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the recommended dose in patients 6-16 years of age, weighing 20 or less than 50 kg

50 mg once daily

100 mg once daily

25 mg once daily

3.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

What is the recommended dose in patients 6-16 years of age, weighing more than or equals to 50 kg

50 mg once a day

25 mg once a day

100 mg once a day

4.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

The safety and efficacy use in of children has not been established from what age in paediatric population?

6 months-2 years

2-6 years

6 months-less than 6 years

6 years and younger

5.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Concomitant use of fluoroquinolones with ACE inhibitors/Renin-Angiotensin is contraindicated in which patients?

Only moderate renal impairment

Only severe renal impairment

Mild to noderate renal impairment

Moderate to severe renal impairment

6.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

COZAAR is safe for administration with aliskerin in patients with diabetes?

FALSE

TRUE

7.

MULTIPLE CHOICE QUESTION

30 sec • 5 pts

Administration of aliskerin with COZAAR in patients with diabetes should be given with caution?

TRUE

FALSE

8.

FILL IN THE BLANK QUESTION

1 min • 5 pts

What should be assessed before initiating treatment with fluoroquinolones or ACE inhibitors/Renin Angiotensin receptor blockers?